Dr. Richard L. Thalman v. First Hospital Laboratories, Inc.

CourtDistrict Court, S.D. Illinois
DecidedMarch 29, 2022
Docket3:21-cv-00543
StatusUnknown

This text of Dr. Richard L. Thalman v. First Hospital Laboratories, Inc. (Dr. Richard L. Thalman v. First Hospital Laboratories, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dr. Richard L. Thalman v. First Hospital Laboratories, Inc., (S.D. Ill. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS DR. RICHARD L. THALMAN, d/b/a THALMAN CHIROPRACTIC & WELLNESS CENTER, on behalf of himself and all others similarly situated, Plaintiff, v. Case No. 3:21-CV-543-NJR FIRST HOSPITAL LABORATORIES, INC., d/b/a FSSOLUTIONS, and JOHN DOES 1-10, Defendants. MEMORANDUM AND ORDER ROSENSTENGEL, Chief Judge: This case arises under the Telephone Consumer Protection Act, 47 U.S.C. § 227 (“TCPA”), as well as Illinois state law. Plaintiff Dr. Richard Thalman, d/b/a Thalman Chiropractic & Wellness Center, complains that he received two unsolicited faxes, totaling 19 pages, from Defendant First Hospital Laboratories, d/b/a FSSolutions (“FSSolutions”). (Doc. 1). His lawsuit, brought as a putative class action, alleges four counts: a claim under the TCPA; a claim under the Illinois Consumer Fraud Act (“IFCA”); conversion; and trespass to chattels. (Id.). FSSolutions has now moved to dismiss the complaint for failure to state a claim

under Rule 12(b)(6) of the Federal Rules of Civil Procedure. (Doc. 14). FSSolutions argues the faxes it sent were not “unsolicited advertisements” under the TCPA, it did not engage in any unfair business practice or cause substantial injury under the IFCA, and Thalman has not alleged more than a de minimus injury sufficient to state a claim for conversion or trespass to chattels. (Id.). Thalman filed a response in opposition (Doc. 16), and

FSSolutions filed a reply (Doc. 17). For the reasons set forth below, the Court finds the faxes were not unsolicited advertisements under the TCPA. FACTUAL BACKGROUND FSSolutions provides background checks, as well as employment and medical screening and monitoring services on a nationwide basis. (Doc. 1 at ¶ 13). As part of these services, FSSolutions conducts drug, alcohol, medical, and other testing of prospective

employees and others. (Id. at ¶ 14). On its website, FSSolutions bills itself as “one of the largest privately held third-party administrators (TPA) of drug and alcohol testing in the country.” (Id. at ¶ 15). The website further states: “With over 15,000 locations, FSSolutions has the largest collection site & provider network in the industry. We continue to expand our network by forging new partnerships every day. That way, no matter where you are,

a site is never far away.” (Id. at ¶ 16). In order to fulfill its contracts, FSSolutions enters into business relationships with medical providers in the areas where it seeks to offer screening and monitoring services. (Id. at ¶ 17). Thalman is a chiropractic physician and a certified Department of Transportation (DOT) medical examiner located in Carbondale, Illinois, and doing business as Thalman

Chiropractic and Wellness Center. Thalman received a fax from FSSolutions on May 27, 2021. (Doc. 1-1). The cover page of the fax, along with the sender information, stated: We would like to send our donors to you for occupational health services, such as physicals, drug screens, titers, and vaccinations. Not Solicitation – We would like to utilize your services.” (Id.). The next page was a letter from Melissa Gagnon, a Procurement Associate with FSSolutions. The letter explained that FSSolutions is a national TPA for a variety of

workplace, staffing, and transportation accounts. (Id.). The company’s clients include DOT truckers and traveling medical professionals with a need for occupational health services and on-site urine drug screening. FSSolutions stated that it received Thalman’s information from the Quest Preferred Providers list, and they were interested in using Thalman’s facility for services. (Id.). The fax included FSSolutions’ provider agreement, instructions for submitting invoices to FSSolutions, and FSSolutions’ schedule of fees it

pays providers like Thalman for performing specific services. (Id.). On June 2, 2021, Thalman received a second fax from FSSolutions. (Doc. 1-2). The fax contained the same cover page, but this time the letter from Ms. Gagnon requested confirmation that Thalman received the contract sent in the first fax. It further stated: “We would like to: 1. Add your site into our database as an option for our candidates to receive

services or 2. Update your site profile in our database as we were recently informed that our services and pricing do not match what you offer.” (Id.). It again included FSSolutions’ provider agreement and service list. (Id.). Five days later, Thalman filed this lawsuit. (Doc. 1). He claims generally that unsolicited fax advertising damages recipients in that it deprives them of their paper, ink,

toner, and use of their fax machine. It also prevents fax machines from receiving and sending authorized faxes, causes wear and tear on fax machines, and requires labor to attempt to identify the source and purpose of the unsolicited faxes. (Id. at ¶ 2). With regard to the faxes at issue, Thalman alleges he did not authorize FSSolutions to send the faxes to him. (Id. at ¶ 27). The purpose of these faxes, he claims, was to solicit him to enter into a contractual business relationship. (Doc. 1 at ¶ 18). He further alleges, on

information and belief, that FSSolutions sends these faxes as part of a mass broadcasting of faxes to healthcare provides across the United States. (Id. at ¶ 21). Thalman claims FSSolutions derived economic benefit from sending the faxes and negligently or willfully violated his rights. (Id. at ¶¶ 25-26). As relief, Thalman seeks actual damages, statutory damages, injunctive relief, and attorney fees and costs. LEGAL STANDARD

The purpose of a motion to dismiss under Rule 12(b)(6) is to evaluate the adequacy of a complaint, not to determine the merits of the case or decide whether a plaintiff will ultimately prevail. Gibson v. City of Chicago, 910 F.2d 1510, 1520 (7th Cir. 1990). To survive a Rule 12(b)(6) motion, the plaintiff only needs to allege enough facts to state a claim for relief that is plausible on its face. Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570 (2007).

A plaintiff need not plead detailed factual allegations, but must provide “more than labels and conclusions, and a formulaic recitation of the elements.” Id. In deciding a motion to dismiss under Rule 12(b)(6), the Court accepts as true all well-pleaded facts in the complaint and draws all reasonable inferences in the plaintiff’s favor. Burke v. 401 N. Wabash Venture, LLC, 714 F.3d 501, 504 (7th Cir. 2013). Taken

together, the factual allegations contained within a complaint must “raise a right to relief above the speculative level, on the assumption that all the allegations in the complaint are true (even if doubtful in fact).” Twombly, 550 U.S. at 555 (internal citations omitted). DISCUSSION FSSolutions moves to dismiss the Complaint for several reasons. First, it argues Thalman has failed to state a claim under the plain language of the TCPA when the faxes

were not “unsolicited advertisements.” Second, it claims the faxes were excluded from the prohibition on “unsolicited advertisements” under FCC interpretations of the TCPA. Finally, FSSolutions asserts Thalman has failed to state a claim under the Illinois Consumer Fraud Act and under Illinois common law. I. Thalman Has Failed to State a Claim Under the TCPA Because the Faxes Were Not Unsolicited Advertisements

The TCPA, 47 U.S.C. § 227

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Michael Burke v. 401 N. Wabash Venture, L.L.C.
714 F.3d 501 (Seventh Circuit, 2013)
Robert W. Mauthe, M.D. P.C. v. Optum, Inc.
925 F.3d 129 (Third Circuit, 2019)
Richard Fischbein v. Olson Research Group Inc
959 F.3d 559 (Third Circuit, 2020)
Gibson v. City of Chicago
910 F.2d 1510 (Seventh Circuit, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
Dr. Richard L. Thalman v. First Hospital Laboratories, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/dr-richard-l-thalman-v-first-hospital-laboratories-inc-ilsd-2022.